Literature DB >> 27764044

Serous Cystadenoma of the Pancreas Showing Uptake on 68Ga PSMA PET/CT.

Mico Chan1, Geoffrey Paul Schembri, Edward Hsiao.   

Abstract

Ga prostate-specific membrane antigen (PSMA) PET/CT is increasingly used to evaluate extent of disease in prostate carcinoma. Several other benign and malignant pathologies have also been reported to demonstrate PSMA avidity. We present a case of serous cystadenoma of the pancreas showing focal uptake on PSMA PET/CT.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27764044     DOI： 10.1097/RLU.0000000000001423

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN： 0363-9762            Impact factor:   7.794


  9 in total

1.  Incidental finding of [68Ga]Ga-PSMA-avid intraductal papillary mucinous neoplasm.

Authors:  D Calabrò; L Zanoni; C Mosconi; A Farolfi; R Golfieri; F Matteucci; P Caroli; S Fanti; P Castellucci
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-07       Impact factor: 9.236

2.  Proposal for a Structured Reporting System for Prostate-Specific Membrane Antigen-Targeted PET Imaging: PSMA-RADS Version 1.0.

Authors:  Steven P Rowe; Kenneth J Pienta; Martin G Pomper; Michael A Gorin
Journal:  J Nucl Med       Date:  2017-09-08       Impact factor: 10.057

3.  [68Ga]Ga-PSMA-11 in prostate cancer: a comprehensive review.

Authors:  Frédéric Bois; Camille Noirot; Sébastien Dietemann; Ismini C Mainta; Thomas Zilli; Valentina Garibotto; Martin A Walter
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-12-15

4.  Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenue.

Authors:  Venkata Subramanian Krishnaraju; Rajender Kumar; Bhagwant Rai Mittal; Vishal Sharma; Harjeet Singh; Ritambhra Nada; Amanjit Bal; Manish Rohilla; Harmandeep Singh; Surinder S Rana
Journal:  Eur Radiol       Date:  2020-10-01       Impact factor: 5.315

Review 5.  Targeting PSMA by radioligands in non-prostate disease-current status and future perspectives.

Authors:  Philipp Backhaus; Benjamin Noto; Nemanja Avramovic; Lena Sophie Grubert; Sebastian Huss; Martin Bögemann; Lars Stegger; Matthias Weckesser; Michael Schäfers; Kambiz Rahbar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-01-15       Impact factor: 9.236

Review 6.  Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging.

Authors:  Sara Sheikhbahaei; Ali Afshar-Oromieh; Matthias Eiber; Lilja B Solnes; Mehrbod S Javadi; Ashley E Ross; Kenneth J Pienta; Mohamad E Allaf; Uwe Haberkorn; Martin G Pomper; Michael A Gorin; Steven P Rowe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-01       Impact factor: 9.236

7.  Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis.

Authors:  Thomas J W Klein Nulent; Robert J J van Es; Gerard C Krijger; Remco de Bree; Stefan M Willems; Bart de Keizer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-07       Impact factor: 9.236

8.  Demonstration of 68Ga-prostate-specific Membrane Antigen Uptake in Metastatic Pancreatic Neuroendocrine Tumor.

Authors:  Meghana Prabhu; Nishikant Avinash Damle; Ravikant Gupta; Saurabh Arora; Sreedharan Thankarajan Arunraj; Chandrasekhar Bal
Journal:  Indian J Nucl Med       Date:  2018 Jul-Sep

9.  Nonspecific Uptake of 68Ga-Prostate-Specific Membrane Antigen in Diseases other than Prostate Malignancy on Positron Emission Tomography/Computed Tomography Imaging: A Pictorial Assay and Review of Literature.

Authors:  Dharmender Malik; Apurva Sood; Bhagwant Rai Mittal; Harmandeep Singh; Rajender Kumar Basher; Jaya Shukla; Anish Bhattacharya; Shrawan Kumar Singh
Journal:  Indian J Nucl Med       Date:  2018 Oct-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.